000 | 01338 a2200289 4500 | ||
---|---|---|---|
005 | 20250516233525.0 | ||
264 | 0 | _c20150710 | |
008 | 201507s 0 0 eng d | ||
022 | _a1557-3265 | ||
024 | 7 |
_a10.1158/1078-0432.CCR-14-2306 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPoliti, Katerina | |
245 | 0 | 0 |
_aPerfect ALKemy: optimizing the use of ALK-directed therapies in lung cancer. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cNov 2014 |
||
300 |
_a5576-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Comment | ||
650 | 0 | 4 |
_aCarbazoles _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
700 | 1 | _aGettinger, Scott | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 20 _gno. 22 _gp. 5576-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-14-2306 _zAvailable from publisher's website |
999 |
_c24197502 _d24197502 |